 |
|
|
| |
Experiences with long acting injectable ART: a qualitative study among PLHIV participating in a Phase II study of Cabotegravir + Rilpivirine (LATTE-2) in the United States and Spain
|
| |
| |
Reported by Jules Levin
Durban 2016 July 18-22
Deanna Kerrigan1, Andrea Mantsios1, David Margolis2, Miranda Murray2
1Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
2ViiV Healthcare, Research Triangle Park, USA & London, UK
|
| |
|
|
|
|
|
